The startup has developed a medical device that automates the skin prick allergy test, enhancing precision and speed while minimizing manual intervention. This technology enables laboratories and hospitals to efficiently collect and store test data in digital format, facilitating comprehensive statistical analysis.
Funding
$1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional allergy skin prick tests (SPT) rely on manual reading and data collection, leading to potential inconsistencies and inefficiencies in clinical workflows. The subjective nature of manual readings can also introduce variability in test results, impacting diagnostic accuracy.
Solution
Nexkin Medical offers a digital solution for allergy testing, centered around the Nexkin DSPT (Digital Skin Prick Test) medical device. This device automates the reading and digitalization of skin prick tests, enhancing precision and speed while minimizing manual intervention. The system streamlines clinical procedures by integrating digital workflows and enabling efficient data storage, analysis, and management. By reducing subjectivity and increasing procedure consistency, Nexkin DSPT aims to improve the objectivity and standardization of allergy testing.
Target Audience
The primary target audience includes allergists, hospitals, and laboratories seeking to improve the efficiency, accuracy, and standardization of allergy skin prick testing.
Features
- Digital wheal detection and digitalization for skin prick allergy tests
- Fast SPT reading to accelerate test reading and reduce manual procedures
- Digital data storage, analysis, and management to avoid paper burden
- Easy-to-use interface for managing, reading, and visualizing the Digital Skin Prick Test
- Reduced physical contact with patients to improve hygiene for both patients and health professionals
- Increased procedure consistency and measurement objectivity to reduce subjectivity
- Seamless integration into existing allergy testing workflows
- Nexkin IDT functionality for digitalizing intradermal allergy tests for drugs